Not yet recruiting
Testing inotuzumab ozogamicin and blinatumomab with drug combination for children with relapsed precursor B-cell acute lymphoblastic leukemia
Not yet recruitingRegistered drugNo placebo
Testing inotuzumab ozogamicin and blinatumomab with drug combination for children with relapsed precursor B-cell acute lymphoblastic leukemia
Registered drugNo placebo
- Substances:BlinatumomabCyclophosphamide+15
Countries:
Austria
Austria- Participants:0–17 years · 18–64 years
- Substances:Blinatumomab
- Sponsor:Charite Universitaetsmedizin Berlin KöR




